Monarch LifeSciences Enters Agreement with GeneGo to Provide Pathway Analysis Services Using 1-2-3 Workflow
News Jun 19, 2007
GeneGo, Inc. has announced that Monarch LifeSciences will be offering pathway analysis add on services to their customers. Monarch is a contract research organization with expertise in protein biomarker discovery, development and validation.
The 1-2-3 Workflow from GeneGo automatically uploads proteomics data, compares the datasets, identifies common, similar and unique components of the datasets, conducts enrichment analysis in multiple ontologies such as diseases, canonical pathways and functional processes; calculates the most relevant networks and the focal hub proteins. The end product is a comprehensive Word report.
"We are very pleased to be working with Monarch as they offer excellent proteomics services, which is a growing OMICs field," said Julie Bryant, GeneGo's VP of Business Development. "Our goal in development of 1-2-3 Workflow was to adapt our functional data analysis technology for occasional users, which means automation and ease of use without a compromise on quality. We believe that Monarch LifeSciences' customers will be very happy with the analysis provided."
"Our goal is to provide our customers with reliable proteomics data that can easily integrate into their research programs," said Lauri Caviston, Monarch LifeSciences' VP of Business Development. "GeneGo provides an excellent tool for taking the data we generate to the next level."
Genome-wide association studies (GWAS) look at large populations to find genes that contribute to common, multi-gene traits like height or obesity. These comprehensive studies frequently turn up large numbers of tiny genetic variations that occur more often in people who are tall, obese, etc. So which genes should scientists investigate further?READ MORE
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.